TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00800917 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03110640 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00615758 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00615758 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01259505 — Predictive Biomarker (PRD): KIF20A mRNA
Genes: KIF20A; MKLP2; RAB6KIFL
Study NCT01259505 — Predictive Biomarker (PRD): DEPDC1 mRNA
Genes: DEPDC1; DEPDC1A
Study NCT01259505 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04299490 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00404677 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT00404677 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04220684 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study NCT01753856 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT04358120 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01217840 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01217840 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01217840 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01217840 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01217840 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01764321 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03352622 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01587703 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT01587703 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03060356 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00615498 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03601689 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01823185 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02829099 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT01263223 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01636258 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03600506 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01314534 — Predictive Biomarker (PRD): KCNN1 mRNA
Genes: KCNN1; SK
Study NCT02331914 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT02331914 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT02331914 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01035515 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03731611 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00000105 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02395380 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00605384 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00597025 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00291928 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02919865 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT04459091 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03398967 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03398967 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01868750 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03412487 — Predictive Biomarker (PRD): PTPRC
Genes: LCA; T200; GP180
Study NCT03412487 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT04136093 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00197418 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00002942 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00314093 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00314093 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT02905539 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT01987505 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04224649 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02657174 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02657174 — Safety Biomarker (SAF): Interleukin 1
Study NCT02657174 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02657174 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT02234089 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00266136 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00672711 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT03124875 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT03415841 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01676844 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT03545165 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03321123 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03321123 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01366209 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01414283 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04021940 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03344250 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00321945 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00150722 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03869346 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01220843 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT01220843 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03577691 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02495441 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT02305797 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT01335984 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02677467 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01322178 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00039052 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT01050426 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01922128 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00561236 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01138033 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT00698360 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01215994 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01215994 — Safety Biomarker (SAF): 51Cr-EDTA
Study NCT00307294 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01155232 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00118963 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00677612 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00677612 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00677612 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04563923 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT03156543 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03128944 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04010357 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT01842074 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT02050529 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03111901 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03547648 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00560976 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00193154 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT00193154 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00101062 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02066870 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01247740 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study NCT01327521 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT04397653 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04397653 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02280785 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00635960 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00300937 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00936585 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT02130973 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01971411 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04833504 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04833504 — Predictive Biomarker (PRD): IL7 mRNA
Genes: IL7
Study NCT04833504 — Safety Biomarker (SAF): C-C motif chemokine 19
Genes: CCL19; ELC; MIP3B; SCYA19
Study NCT03516591 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT01813591 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01813591 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT03656328 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01294293 — Predictive Biomarker (PRD): TLR8 mRNA
Genes: TLR8; UNQ249/PRO286
Study NCT03970798 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03970798 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT03970798 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT00211809 — Predictive Biomarker (PRD): SRI mRNA
Genes: SRI
Study NCT02579044 — Predictive Biomarker (PRD): ZMPSTE24
Genes: FACE-1; Ste24p; STE24; HGPS; PRO1
Study NCT02104713 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04105153 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04105153 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02431234 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT03932721 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT02049957 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02049957 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02049957 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04101825 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04358380 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04358380 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00001723 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01092559 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00632242 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04304807 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04357678 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02870296 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT04606082 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT01722890 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04623138 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02401815 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01366170 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT01366170 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01366170 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01366170 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT01366170 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT05785871 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05785871 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00162201 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01255657 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01255657 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02308085 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02233504 — Surrogate Endpoint (SUR): Hematologic response
Study NCT04521075 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT01306591 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01548521 — Predictive Biomarker (PRD): MAGEL2 mRNA
Genes: MAGEL2; NDNL1
Study NCT03313544 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT03313544 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00349284 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02106091 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01359397 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01359397 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03755102 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04441606 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02579408 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT01749345 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01749345 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02501473 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT00006278 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00006278 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT04369521 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04369521 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01000272 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03415191 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00020475 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06153576 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00846430 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02496273 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03916328 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01990989 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03580655 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01652560 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01023750 — Predictive Biomarker (PRD): APOA5 mRNA
Genes: APOA5; RAP3; UNQ411/PRO773
Study NCT01023750 — Predictive Biomarker (PRD): GCKR mRNA
Genes: GCKR
Study NCT03007576 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04271605 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02387853 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00002925 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00052208 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00052208 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02600377 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05792891 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00799604 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03950167 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT00053040 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT00523354 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01093807 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04341389 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04237987 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04334629 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01723852 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00237198 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study NCT00376662 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00041483 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03236974 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03236974 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03236974 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00905398 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00905398 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01745172 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00208832 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02883153 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT03907553 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04469517 — Predictive Biomarker (PRD): ALK
Genes: CD246; ALK1
Study NCT04469517 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT03816839 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03816839 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03314402 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT01901198 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02726646 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02726646 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03954756 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00647790 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00647790 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04606732 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03974997 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03974997 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study NCT00924456 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02329730 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02078778 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04238130 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00995826 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01793649 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT02894918 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03063346 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04471428 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04471428 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00733408 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04232124 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03283449 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03849300 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04273854 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02397902 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02275351 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA